Search

everythinglearnresearchcommunity

for

Search:↓

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.

The document concludes that various clinical methods are used to assess ageing skin and the effectiveness of anti-ageing products.

Bald men are often viewed more negatively and as older than they really are.

Home-use cosmetic laser and light devices show modest results for hair removal and acne treatment, but more research is needed for confirmation.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

Mothers have more hair proteins than their children, with age-related differences in protein patterns, and some proteins in hair could indicate early childhood development.

The congress showed that psychological therapy can help skin condition patients, social media affects acne stigma, education improves atopic dermatitis, and patient satisfaction in dermatology is high, especially with good doctor engagement.

New treatments for skin and hair repair show promise, but further improvements are needed.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

Hair loss reduces hair thickness and coverage, but drug treatments mainly revive dormant hairs rather than reverse thinning; patients often undervalue their hair loss severity.

The review suggests that a special cell-derived treatment shows promise for various skin conditions and hair growth but needs more research for confirmation.

Hair proteins in preschool children and their mothers could indicate developmental changes and health status.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Severe hair loss links to metabolic issues in older men with psoriasis.

PRP treatment helps hair growth in most cases, but more research needed.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

PRP injections improve hair density in male hair loss.

Actual harvested hair follicles were fewer and differed in type from estimated, with older patients and those with multiple transplants needing more careful planning.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Epigenetic differences affect hair loss in identical Japanese male twins.

The BASP classification is more reliable than the Norwood-Hamilton for classifying hair loss in men and women.